NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 196 filers reported holding NEVRO CORP in Q2 2018. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $748,831 | -43.6% | 38,961 | +6.2% | 0.00% | -100.0% |
| Q2 2023 | $1,326,632 | 0.0% | 36,698 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,326,632 | -8.7% | 36,698 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,453,242 | -99.9% | 36,698 | +5.7% | 0.00% | 0.0% |
| Q3 2022 | $1,617,907,000 | -15.0% | 34,719 | -20.1% | 0.00% | 0.0% |
| Q2 2022 | $1,904,238,000 | -40.8% | 43,446 | -2.3% | 0.00% | 0.0% |
| Q1 2022 | $3,217,239,000 | +5.0% | 44,480 | +17.7% | 0.00% | 0.0% |
| Q4 2021 | $3,064,770,000 | -29.7% | 37,804 | +0.9% | 0.00% | -50.0% |
| Q3 2021 | $4,359,014,000 | -30.7% | 37,455 | -1.2% | 0.00% | -33.3% |
| Q2 2021 | $6,287,088,000 | +19.9% | 37,922 | +0.9% | 0.00% | +50.0% |
| Q1 2021 | $5,244,505,000 | -18.7% | 37,595 | +0.8% | 0.00% | -33.3% |
| Q4 2020 | $6,453,687,000 | +30.4% | 37,283 | +4.9% | 0.00% | 0.0% |
| Q3 2020 | $4,949,748,000 | +20.2% | 35,533 | +3.1% | 0.00% | 0.0% |
| Q2 2020 | $4,118,011,000 | +15.3% | 34,469 | -3.5% | 0.00% | 0.0% |
| Q1 2020 | $3,572,785,000 | -10.0% | 35,735 | +5.7% | 0.00% | +50.0% |
| Q4 2019 | $3,971,912,000 | +37.2% | 33,792 | +0.4% | 0.00% | 0.0% |
| Q3 2019 | $2,894,353,000 | +66.6% | 33,667 | +25.6% | 0.00% | +100.0% |
| Q2 2019 | $1,737,444,000 | +35.8% | 26,800 | +30.9% | 0.00% | 0.0% |
| Q1 2019 | $1,279,830,000 | +229.1% | 20,474 | +104.7% | 0.00% | – |
| Q4 2018 | $388,900,000 | -64.2% | 10,000 | -47.5% | 0.00% | -100.0% |
| Q3 2018 | $1,084,995,000 | -26.5% | 19,035 | +2.9% | 0.00% | 0.0% |
| Q2 2018 | $1,476,427,000 | -2.6% | 18,490 | +5.8% | 0.00% | 0.0% |
| Q1 2018 | $1,515,339,000 | +46.4% | 17,484 | +16.6% | 0.00% | 0.0% |
| Q4 2017 | $1,034,910,000 | -28.0% | 14,990 | -5.2% | 0.00% | 0.0% |
| Q3 2017 | $1,437,630,000 | +49.4% | 15,819 | +22.3% | 0.00% | 0.0% |
| Q2 2017 | $962,380,000 | -9.9% | 12,930 | +13.5% | 0.00% | 0.0% |
| Q1 2017 | $1,067,899,000 | +350030.8% | 11,397 | +171.4% | 0.00% | – |
| Q4 2016 | $305,000 | -73.2% | 4,200 | -61.5% | 0.00% | -100.0% |
| Q3 2016 | $1,139,000 | +93.1% | 10,908 | +36.4% | 0.00% | 0.0% |
| Q2 2016 | $590,000 | +47.9% | 8,000 | +12.7% | 0.00% | – |
| Q1 2016 | $399,000 | +9.3% | 7,100 | +31.5% | 0.00% | – |
| Q4 2015 | $365,000 | +57.3% | 5,400 | +8.0% | 0.00% | – |
| Q3 2015 | $232,000 | -13.8% | 5,000 | 0.0% | 0.00% | – |
| Q2 2015 | $269,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |